Legal settlements

1010 WINS Newsroom
September 25, 2019 - 4:16 pm
OxyContin maker Purdue Pharma's tentative legal settlement over the toll of the nation's opioid crisis is unlikely to reverse the consequences of the epidemic in the hardest-hit towns and regions, according to a report released Wednesday. Purdue reached a tentative deal this month to resolve the...
Read More
FILE - In this May 23, 2019, file photo former Nissan chairman Carlos Ghosn, center, arrives at Tokyo District Court for a pre-trial meeting in Tokyo. Nissan has agreed to pay $15 million and its former chairman Carlos Ghosn is paying $1 million to settle federal regulators' civil fraud charges of hiding from investors more than $140 million in compensation and retirement benefits for Ghosn. (Ren Onuma/Kyodo News via AP, File)
1010 WINS Newsroom
September 23, 2019 - 8:03 pm
WASHINGTON (AP) — Nissan will pay $15 million and former chairman Carlos Ghosn will pay $1 million to settle allegations by U.S. regulators that they hid more than $140 million of Ghosn's retirement benefits from investors. The Securities and Exchange Commission announced Monday the settlement of...
Read More
FILE - In this Oct. 26, 2016, file photo, Louisville NCAA college basketball head coach Rick Pitino answers a question during the Atlantic Coast Conference media day in Charlotte, N.C. The University of Louisville Athletic Association and Rick Pitino have agreed to settle a federal lawsuit, with the former Cardinals men's basketball coach's changing his termination to a resignation. The settlement unanimously approved Wednesday, Sept. 18, 2019, by the ULAA states that Pitino has received compensation and the school agrees not to pursue further legal action. (AP Photo/Bob Leverone, FIle)
1010 WINS Newsroom
September 18, 2019 - 5:15 pm
LOUISVILLE, Ky. (AP) — A fiercely competitive coach on the court, Rick Pitino didn't want to fight in one anymore. So the University of Louisville Athletic Association and Pitino settled lawsuits stemming from his departure from the school, with the former men's basketball coach's personnel file...
Read More
FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
1010 WINS Newsroom
September 17, 2019 - 7:40 pm
WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
1010 WINS Newsroom
September 17, 2019 - 4:20 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
1010 WINS Newsroom
September 17, 2019 - 7:29 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
1010 WINS Newsroom
September 16, 2019 - 4:48 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
Display cars are parked at a Volkswagen dealership in Sydney, Monday, Sept. 16, 2019. Volkswagen has agreed to pay up to 127 million Australian dollars ($87 million) to settle an Australian class action stemming from the 2015 diesel emissions scandal, the German automaker and a lawyer said Monday. (AP Photo/Rick Rycroft)
1010 WINS Newsroom
September 16, 2019 - 3:41 am
CANBERRA, Australia (AP) — Volkswagen has agreed to pay up to 127 million Australian dollars ($87 million) to settle an Australian class action stemming from the 2015 diesel emissions scandal, the German automaker and a lawyer said Monday. The settlement was announced in the Federal Court in Sydney...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
1010 WINS Newsroom
September 15, 2019 - 11:46 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
FILE - This Jan. 11, 2018 file photo shows Judge Dan Polster in his office, in Cleveland. Attorneys representing eight drug distributors, pharmacies and retailers facing trial for their roles in the national opioid crisis are seeking to disqualify the federal judge overseeing their cases saying he’s shown clear bias in his efforts to obtain a multi-billion dollar global settlement. The motion was filed late Friday, Sept. 13, 2019, in U.S. District Court in Cleveland, where Judge Dan Polster presides over most of the 2,000 lawsuits filed by state, local and tribal governments. Polster has not responded. (AP Photo/Tony Dejak, File)
1010 WINS Newsroom
September 14, 2019 - 4:27 pm
CLEVELAND (AP) — Attorneys for eight drug distributors, pharmacies and retailers facing trial next month for their roles in the opioid crisis want to disqualify the federal judge overseeing their cases, saying he has shown bias in his effort to obtain a multibillion-dollar global settlement...
Read More

Pages